China encourages researching and developing new medicine

China encourages researching and developing new medicine
Www.xinhuanet.com Beijing 7 Cable of the 18th of moon (reporter Wang Xi, white Ying) Whom Information Office of the State Council publish 18 " medicines of China supervise the state " the white paper say " safely, the country especially examines and comments the examination and approval procedures, encourage formulating new medicine and researches and develops and treat new medicine of the critical disease of the difficulty. The white paper says, new medicine which is applicable to the special procedure includes: Have not been listed valid composition and preparation drawn from materials such as the plant, animal, mineral,etc. sold at home; Newly discovered crude drugs and preparation; Medicinal chemicals, preparation, biologicals that it is listing to get permission at home and abroad; And disease of treating AIDS, malignant tumour, rare and ill etc. has obviously clinical new medicine which treat the advantage; There is not new medicine of disease of effective treatment means yet in the treatment. Since 1998 by the end of 2007, 78 a kind of new medicine in all obtained approval. The white paper says, the engineering levels and production technologies of pharmacy enterprises have improvement greatly, initiate one new craft, new technology, new method, such as two of vitamin C ferment and the rhizome of Chinese goldthread usually formate, high the intersection of purity and the intersection of urine and the intersection of kinase and production method and device,etc.. Such new crafts as penicillin spore high unit bacterium seed selection and fermenting correspondingly, very beginning spore's fungus plain C are fermented reach the advanced international standards. China not merely can produce the medium-sized medical apparatus for exporting, the research in can wear technology, biomedical material and organizational project in year ing etc., also entering world top progressively. The white paper points out, in order to prevent imitation medicine from utilizing new medicine to develop the data free, the motive power of damaging new medicine and developing, China fulfils the commitment of accession to the WTO conscientiously, implement the medicines data protection system. 2002, revise " implementing regulations of the Pharmaceutical Administration Law of the PRC ", stipulate to producing or selling the test data and other made and not revealed by oneself that the producers or sellers who contain new chemical composition medicines and permit submit Data, offer 6 to protect time limit.

|